LU72306A1 - - Google Patents

Info

Publication number
LU72306A1
LU72306A1 LU72306A LU72306A LU72306A1 LU 72306 A1 LU72306 A1 LU 72306A1 LU 72306 A LU72306 A LU 72306A LU 72306 A LU72306 A LU 72306A LU 72306 A1 LU72306 A1 LU 72306A1
Authority
LU
Luxembourg
Application number
LU72306A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU72306A1 publication Critical patent/LU72306A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU72306A 1974-04-17 1975-04-17 LU72306A1 (en])

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
LU72306A1 true LU72306A1 (en]) 1976-03-17

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
LU72306A LU72306A1 (en]) 1974-04-17 1975-04-17

Country Status (21)

Country Link
US (1) US4009847A (en])
JP (1) JPS50148349A (en])
AR (1) AR208545A1 (en])
CA (1) CA1047042A (en])
CH (1) CH611292A5 (en])
DD (1) DD117223A5 (en])
DE (1) DE2516554A1 (en])
DK (1) DK164175A (en])
ES (1) ES436648A1 (en])
FI (1) FI751128A7 (en])
FR (1) FR2267773B1 (en])
GB (1) GB1461209A (en])
HU (1) HU173052B (en])
IE (1) IE41143B1 (en])
IL (1) IL47095A (en])
LU (1) LU72306A1 (en])
NL (1) NL7504570A (en])
NO (1) NO144071C (en])
PH (1) PH11722A (en])
SE (1) SE417965B (en])
YU (1) YU96075A (en])

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US7329670B1 (en) * 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US7517880B2 (en) * 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
WO2000041698A1 (en) * 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7351834B1 (en) 1999-01-13 2008-04-01 Bayer Pharmaceuticals Corporation ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
EP2295057B1 (en) * 2001-12-03 2013-01-23 Bayer HealthCare LLC Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
US20040023961A1 (en) * 2002-02-11 2004-02-05 Bayer Corporation Aryl ureas with raf kinase and angiogenisis inhibiting activity
AU2003209118A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
AU2003209119A1 (en) * 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
EP2324825A1 (en) * 2002-02-11 2011-05-25 Bayer Healthcare LLC Aryl ureas with angiogenesis inhibiting activity
US7557129B2 (en) * 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
DE602004011340T2 (de) * 2003-05-20 2008-11-06 Bayer Healthcare Llc Diaryl-harnstoffe mit kinasehemmender wirkung
PT1663978E (pt) * 2003-07-23 2008-02-15 Bayer Pharmaceuticals Corp Omega-carboxiaril difenil ureia substituída por flúor para o tratamento e a prevenção de doenças e estados patológicos
WO2005110994A2 (en) * 2004-04-30 2005-11-24 Bayer Pharmaceuticals Corporation Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
SE417965B (sv) 1981-04-27
SE7503523L (sv) 1975-10-20
PH11722A (en) 1978-05-30
NO144071B (no) 1981-03-09
IE41143B1 (en) 1979-10-24
DK164175A (da) 1975-10-18
CH611292A5 (en]) 1979-05-31
IL47095A (en) 1978-03-10
FR2267773A1 (en]) 1975-11-14
HU173052B (hu) 1979-02-28
NL7504570A (nl) 1975-10-21
NO751351L (en]) 1975-10-20
FI751128A7 (en]) 1975-10-18
IL47095A0 (en) 1975-06-25
CA1047042A (en) 1979-01-23
JPS50148349A (en]) 1975-11-27
ES436648A1 (es) 1977-08-01
YU96075A (en) 1983-04-27
AR208545A1 (es) 1977-02-15
FR2267773B1 (en]) 1978-08-18
IE41143L (en) 1975-10-17
GB1461209A (en) 1977-01-13
US4009847A (en) 1977-03-01
AU8013575A (en) 1976-10-21
DE2516554A1 (de) 1975-10-30
DD117223A5 (en]) 1976-01-05
NO144071C (no) 1981-06-17

Similar Documents

Publication Publication Date Title
FR2267773B1 (en])
FR2263173B1 (en])
FR2259511A1 (en])
AU7891375A (en])
AU474179B2 (en])
AU6717074A (en])
CS169387B1 (en])
AU7205174A (en])
AU6599774A (en])
AR198999Q (en])
AU479969A (en])
CH584601A5 (en])
AU481600A (en])
AU481544A (en])
AU481723A (en])
AU481001A (en])
AU480625A (en])
AU480541A (en])
AU480360A (en])
BG20647A1 (en])
AU479523A (en])
AU481765A (en])
AU482110A (en])
DD127496A3 (en])
DD119074A5 (en])